Role of the NCoR corepressor complex in the development of insulin resistance
Role of the NCoR corepressor complex in the development of insulin resistance
批准号:
8328959
负责人:
VALENTINA PERISSI
金额:
$24.28万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-25 至 2013-06-30
关键词:
AddressAdipocytesAffectAmericanAnimal ModelBasic ScienceBindingBiochemicalBiological AssayCellsCharacteristicsChemicalsComplexCytoplasmDataDefectDevelopmentDiabetes MellitusDown-RegulationEnzymesExcisionGPS2 geneGTP-Binding ProteinsGene ExpressionGene Expression RegulationGenesGeneticGenetic TranscriptionHumanIncidenceInflammationInflammatoryInsulinInsulin ResistanceInsulin Signaling PathwayKnockout MiceKnowledgeLeadLinkLocationMAPK8 geneMediatingMetabolic DiseasesMolecularMolecular BiologyNon-Insulin-Dependent Diabetes MellitusNonesterified Fatty AcidsNuclear ReceptorsObesityPathway interactionsPhenotypePhosphorylationPhosphotransferasesPhysiologicalPlayPopulationPrincipal InvestigatorProcessProductionProtein KinaseProteinsReactive Oxygen SpeciesRecruitment ActivityRegulationRegulatory ElementReportingResearchRoleSeriesSerineSignal TransductionSmall Interfering RNAStimulusStressTechniquesTestingTranscription Factor AP-1Transcription Repressor/CorepressorTranscriptional ActivationTranscriptional RegulationUbiquitin-Conjugating EnzymesWestern WorldYeastsbaseblood glucose regulationcofactordesigndiabeticexperiencegenome-wideimprovedin vivoin vivo Modelinhibitor/antagonistinsulin signalingmouse modelnovelnovel therapeutic interventionoverexpressionpreventprogramspromoterresearch studyresponsetranscription factortranslational approach
中文摘要
GPS2最近被报道为一种主要的抑制物复合体的内在成分。
转录,NCoR/SMRT核受体辅阻遏子复合体。而GPS2的特定功能是
大部分未知,我们的初步数据显示,GPS2是必需的,以防止结构性激活
几种转录因子,包括AP1和NFkB。因为GPS2最初是从酵母中分离出来的
结构性G蛋白信号的抑制者,并被证明对TNFa的反应抑制JNK活性,
我们的假设是,GPS2和一种新发现的GPS2相互作用蛋白KIAA1787是内源性的
所需的抑制剂,以防止JNK和IKK激酶途径的异常激活,因此
严格控制已知被激活的大的促炎转录程序
在肥胖和随后的胰岛素抵抗的发展过程中。我们提出了三个具体目标:i)定义
结合微阵列和ChlP芯片技术研究脂肪细胞中依赖GPS2的基因网络;
Ii)研究GPS2和KIAA1787在NFkB调控中的分子机制
和AP1途径;iii)建立动物模型,在体内解决GPS2和KIAA1787与
胰岛素抵抗的发展。候选人佩里西博士在分子生物学方面有很强的背景
之前已经研究了核受体的其他转录协同调节因子NFkB和NFkB的作用
AP1转录因子与本提案旨在结合已有的基础研究特征
她以前用翻译方法研究这些新因素在胰岛素中的作用的经验
耐药性和II型糖尿病。赞助商M.G.罗森菲尔德博士和联合赞助商J.OIefsky博士将
为该项目的实验设计和开发提供科学依据
在糖尿病和炎症研究领域实现独立的候选人。II型糖尿病
是一种复杂的代谢紊乱,影响西方世界6%至20%的人口
它的发病率预计将呈指数级增长,特别是在年轻人中。肥胖,这是
影响了近三分之一的美国人口,现在与胰岛素的发展密切相关
耐药性及其发展为糖尿病。更好地刻画分子基础是如何
炎症通路的生理调节是开发新的治疗方法的关键。
英文摘要
GPS2 has been recently reported as an intrinsic component of one of the major represser complexes in
transcription, the NCoR/SMRT nuclear receptor corepressor complex. While GPS2 specific functions are
mostly unknown, our preliminary data show that GPS2 is required to prevent constitutive activation of
several transcription factors, including AP1 and NFkB. Because GPS2 was originally isolated in yeast as a
suppressor of constitutive G-protein signaling, and it was shown to inhibit JNK activity in response to TNFa,
our hypothesis is that GPS2 and a newly identified GPS2-interacting protein, KIAA1787, are endogenous
inhibitors required for preventing undesired activation of the JNK and IKK kinase pathways and therefore for
keeping under tight control large pro-inflammatory transcription programs that are known to be activated
during obesity and consequent development of insulin resistance. We propose 3 specific aims: i) to define
GPS2-dependent gene networks in adipocytes with a combination of microarray and ChlP-chip techniques;
ii) to investigate the molecular mechanism of GPS2 and KIAA1787 functions in the regulation of the NFkB
and AP1 pathways; iii) to generate animal models to address in vivo GPS2 and KIAA1787 relevance for the
development of insulin resistance. The candidate, Dr. Perissi, has a strong background in molecular biology
and has previously investigated the role of other transcriptional coregulators of nuclear receptors, NFkB and
AP1 transcription factors and with this proposal aims to combine the basic research that has characterized
her previous experience with a translational approach to investigate the role of these novel factors in insulin
resistance and type II diabetes. The Sponsor, Dr. M.G.Rosenfeld, and the co-Sponsor, Dr. J.OIefsky, will
ovelook the experiments design and the development of the project and will provide the scientific support for
the candidate to achieve independence in the field of diabetes and inflammation research. Type II diabetes
is a complex metabolic disorder that affects between 6% and 20% of the population in the Western world
and its incidence is expected to increase exponentially, especially among young people. Obesity, which is
affecting almost a third of the American population, is now tightly link to the development of insulin
resistance and its progression into diabetes. A better characterization of the molecular basis of how the
inflammatory pathways are physiologically regulated is critical to develop novel therapeutic approaches.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Coordination of PAR and Ub signaling in mitochondria
-
批准号:10623889
-
项目类别:
-
资助金额:$43.14万
-
财政年份:2023
-
负责人:VALENTINA PERISSI
-
依托单位:
Regulation of mitochondrial homeostasis through retrograde signaling
-
批准号:9924614
-
项目类别:
-
资助金额:$44.56万
-
财政年份:2018
-
负责人:VALENTINA PERISSI
-
依托单位:
Regulation of mitochondrial homeostasis through retrograde signaling
-
批准号:10133090
-
项目类别:
-
资助金额:$43.83万
-
财政年份:2018
-
负责人:VALENTINA PERISSI
-
依托单位:
Ubiquitin-dependent regulation of inflammation and insulin resistance
-
批准号:9243244
-
项目类别:
-
资助金额:$36.42万
-
财政年份:2014
-
负责人:VALENTINA PERISSI
-
依托单位:
Ubiquitin-dependent regulation of inflammation and insulin resistance
-
批准号:9040938
-
项目类别:
-
资助金额:$36.42万
-
财政年份:2014
-
负责人:VALENTINA PERISSI
-
依托单位:
Role of the NCoR corepressor complex in the development of insulin resistance
-
批准号:8149970
-
项目类别:
-
资助金额:$24.65万
-
财政年份:2010
-
负责人:VALENTINA PERISSI
-
依托单位:
Role of the NCoR corepressor complex in the development of insulin resistance
-
批准号:8138837
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2010
-
负责人:VALENTINA PERISSI
-
依托单位:
Role of the NCoR corepressor complex in the development of insulin resistance
-
批准号:7300065
-
项目类别:
-
资助金额:$8.48万
-
财政年份:2007
-
负责人:VALENTINA PERISSI
-
依托单位:
Role of the NCoR corepressor complex in the development of insulin resistance
-
批准号:7456334
-
项目类别:
-
资助金额:$8.59万
-
财政年份:2007
-
负责人:VALENTINA PERISSI
-
依托单位:
国内基金
海外基金
支链氨基酸代谢紊乱调控“Adipocytes - Macrophages Crosstalk”诱发2型糖尿病脂肪组织功能和结构障碍的作用及机制
-
批准号:81970721
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:陶凌
-
依托单位: